Article Sidebar

PDF (Tiếng Việt)
Published: 2021-02-26
Abstract Views: 357
Views PDF (Tiếng Việt): 253
DOI: https://doi.org/10.52852/tcncyh.v137i1.31
Issue
Vol. 137 No. 1 (2021)
Section
Các bài báo
How to Cite
Hùng, P. V., & Hiếu, N. V. (2021). Evaluating mean time survival of non - small cell lung cancer patients treated with radiofrequency ablation. Journal of Medical Research, 137(1), 118-124. https://doi.org/10.52852/tcncyh.v137i1.31

Evaluating mean time survival of non - small cell lung cancer patients treated with radiofrequency ablation

Pham Vinh Hung, Nguyen Van Hieu

Main Article Content

Abstract

Radiofrequency Ablation (RFA) is a method of using high - frequency alternating current that generates heat to destroy cancer tumor. Damage to tissue depends on the temperature and time of the procedure. This study was conducted to assess the clinical outcomes of 45 non - small cell lung cancer patients (NSC LC) treated with RFA under 2013 CT guidance. The median age of the study patient was 66.0 ± 3.3 (47 - 85), the sex ratio was 2.7: 1. The majority of patients (47.7%) had tumors of less than 30 mm in diameter. The average of progression - free survival (PFS) is 18 months and the average of overall survival (OS) is 27 months. In conclusion, overall survival depends on the stage of NSCLC. Our data suggest that treating NSCLC with RFA method using robotic - assisted CT guidance system is an effective and less complicated method that can significantly improve overall survival.

Article Details

Keywords

Non - small cell lung cancer, Radiofrequency Ablation.

References

1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. and Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018; 68: 394 - 424. https://doi. org/10, 3322/caac. 21492.
2. Nguyễn Bá Đức, Trần Văn Thuấn, Nguyễn Tuyết Mai. Điều trị nội khoa Ung thư. 2010; 81 - 93.
3. Nguyễn Văn Hiếu, Ung thư học. 2015; 153 - 169.
4. Riccardo Lencioni. Interventional procedure overview of percutaneous radiofrequency ablation for primary or secondary lung cancers. National istitute for health and clinical excellence, 2008; 1 - 36.
5. Hoàng Đình Chân và cộng sự. Nghiên cứu các biện pháp chẩn đoán sớm và điều trị phối hợp ung thư phổi. Đề tài cấp nhà nước, chương trình KC 10 - 06, 2005; 12 - 33
6. Bùi Công Toàn, Ung thư phế quản. Thực hành xạ trị bệnh ung thư. NXB Y học, 2003; 306 - 309.
7. Beland. MD. Interventional procedure overview of percutaneous radiofrequency ablation for primary or secondary lung cancers. National istitute for health and clinical excellence, 2010; 1 - 36.
8. Đinh Trọng Toàn, Nguyễn Đức Bằng, Nguyễn Huy Dũng. Đốt u phổi ác tính bằng sóng cao tần ở bệnh nhân không thể phẫu thuật: Nghiên cứu loạt ca lâm sàng trên 32 bệnh nhân. Y Học thành phố Hồ Chí Minh, 2013; 13, 207 - 2013.
9. Fernando MD, Radiofrequency ablation for the treatment of non - small cell lung cancer in marginal surgical candidates, The Journal of Thoracic and Cardiovascular Surgery, 2005; Volume 129, p 639 - 644
10, Penather A. Interventional procedure overview of percutaneous radiofrequency ablation for primary or secondary lung cancers. National istitute for health and clinical excellence,2009; 1 - 36.